These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2558895)

  • 1. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
    Fukagawa Y; Katz JL; Suzuki T
    Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
    Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
    Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
    Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
    Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
    Czlonkowski A; Millan MJ; Herz A
    Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
    [No Abstract]   [Full Text] [Related]  

  • 10. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa receptor mediated opioid dependence in rhesus monkeys.
    Gmerek DE; Woods JH
    Life Sci; 1986 Sep; 39(11):987-92. PubMed ID: 3018406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
    Milanés MV; Vargas ML; Martín MI
    Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats.
    Young GA; Marquis KL; Paquette NC; Gussio RP; Khazan N
    Neuropharmacology; 1989 Aug; 28(8):881-4. PubMed ID: 2550842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
    Bhargava HN; Matwyshyn G; Ramarao P
    Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M; Kameyama T
    Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L; Rivière PJ; Pascaud X; Junien JL
    Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity.
    Vaupel DB; Cone EJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):211-21. PubMed ID: 1846414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.